Gunderson Dettmer has advised Hims & Hers. Hims & Hers Health, Inc. (NYSE: HIMS) has entered into a definitive agreement to acquire YourBio Health, Inc., a...
Hims & Hers Announces Acquisition of YourBio Health
Hims & Hers Acquires Canadian Digital Health Platform Livewell
Gunderson Dettmer has advised Hims & Hers. Hims & Hers (NYSE: HIMS), a leading health and wellness platform, has completed the acquisition of Livewell, a Canadian...
Clari and Salesloft Announce Merger to Create Revenue AI Powerhouse
Gunderson Dettmer has advised Clari. Clari and Salesloft have announced a definitive agreement to merge, forming a leading force in the Revenue Orchestration sector. This transaction...
Hims & Hers to Acquire ZAVA
Gunderson Dettmer and Taylor Wessing advised Hims & Hers on the transaction. Hims & Hers, a leading health and wellness platform (NYSE: HIMS) has entered into...
Hims & Hers to Acquire ZAVA
Gunderson Dettmer has advised Hims & Hers on the transaction. Hims & Hers, a leading health and wellness platform (NYSE: HIMS) has entered into a definitive...
Hims & Hers’ Acquisition of 503B Outsourcing Facility MedisourceRx
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Hims & Hers Health in the transaction. Hims & Hers Health, a multi-specialty telehealth platform, announced its acquisition...
Openwater’s $100 Million Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Openwater in the transaction. Openwater, a medical technology company, announced it secured $100 million financing from new and...
Radar Therapeutics’ $13.4 Million Seed Funding Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Radar Therapeutics on the deal, and Wilson Sonsini Goodrich & Rosati advised Radar Therapeutics on IP matters related...
Alamar Biosciences’ $128 Million Series C Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Alamar Biosciences in the transaction. Alamar Biosciences announced it raised $128 million in Series C financing round. The financing...
LiveRamp’s Acquisition of Habu
Baker McKenzie represented LiveRamp in the transaction, and Gunderson Dettmer represented Habu. LiveRamp (NYSE: RAMP), the leading data collaboration platform, today announced that it has entered...
Star Therapeutics’ $90 Million Series C Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Star Therapeutics in the transaction. Star Therapeutics announced its oversubscribed $90 million Series C financing to continue growth of its...
Faith-based App Hallow’s $50 Million Series C Financing
Gunderson Dettmer represented Hallow on the deal. Hallow, a Catholic meditation and prayer app, announced the close of an additional $50 million in Series C funding bringing the...




































